Kemp J - Search Results

1

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

Nelson H, Kemp J, Berger W, Corren J, Casale T, Dube L, Walton-Bowen K, LaVallee N, Stepanians M. Nelson H, et al. Among authors: kemp j. Ann Allergy Asthma Immunol. 2007 Aug;99(2):178-84. doi: 10.1016/S1081-1206(10)60642-4. Ann Allergy Asthma Immunol. 2007. PMID: 17718106 Clinical Trial.

2

Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma.

Casale TB, Nelson HS, Kemp J, Parasuraman B, Uryniak T, Liljas B. Casale TB, et al. Among authors: kemp j. Ann Allergy Asthma Immunol. 2003 Mar;90(3):323-30. doi: 10.1016/S1081-1206(10)61801-7. Ann Allergy Asthma Immunol. 2003. PMID: 12669896 Clinical Trial.

3

Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma.

Nelson H, Kemp JP, Bieler S, Vaughan LM, Hill MR. Nelson H, et al. Among authors: kemp jp. Chest. 1999 Feb;115(2):329-35. doi: 10.1378/chest.115.2.329. Chest. 1999. PMID: 10027428 Clinical Trial.

4

Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma.

McFadden ER, Casale TB, Edwards TB, Kemp JP, Metzger WJ, Nelson HS, Storms WW, Neidl MJ. McFadden ER, et al. Among authors: kemp jp. J Allergy Clin Immunol. 1999 Jul;104(1):46-52. doi: 10.1016/s0091-6749(99)70112-0. J Allergy Clin Immunol. 1999. PMID: 10400838 Clinical Trial.

5

Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.

Kemp JP, Skoner DP, Szefler SJ, Walton-Bowen K, Cruz-Rivera M, Smith JA. Kemp JP, et al. Ann Allergy Asthma Immunol. 1999 Sep;83(3):231-9. doi: 10.1016/S1081-1206(10)62646-4. Ann Allergy Asthma Immunol. 1999. PMID: 10507269 Clinical Trial.

6

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

Kemp JP, Cook DA, Incaudo GA, Corren J, Kalberg C, Emmett A, Cox FM, Rickard K. Kemp JP, et al. J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):188-95. doi: 10.1016/s0091-6749(98)70383-5. J Allergy Clin Immunol. 1998. PMID: 9500751 Clinical Trial.

7

Safety and clinical efficacy of zileuton in patients with chronic asthma.

Lazarus SC, Lee T, Kemp JP, Wenzel S, Dubé LM, Ochs RF, Carpentier PJ, Lancaster JF. Lazarus SC, et al. Among authors: kemp jp. Am J Manag Care. 1998 Jun;4(6):841-8. Am J Manag Care. 1998. PMID: 10181070 Free article. Clinical Trial.

8

Safety of salmeterol in the maintenance treatment of asthma.

Nathan RA, Seltzer JM, Kemp JP, Chervinsky P, Alexander WJ, Liddle R, Mills R. Nathan RA, et al. Among authors: kemp jp. Ann Allergy Asthma Immunol. 1995 Sep;75(3):243-8. Ann Allergy Asthma Immunol. 1995. PMID: 7552926 Clinical Trial.

9

Efficacy of antileukotriene agents in asthma management.

Nathan RA, Kemp JP; Antileukotriene Working Group. Nathan RA, et al. Among authors: kemp jp. Ann Allergy Asthma Immunol. 2001 Jun;86(6 Suppl 1):9-17. doi: 10.1016/s1081-1206(10)62306-x. Ann Allergy Asthma Immunol. 2001. PMID: 11426917 Review.

10

Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.

Nathan RA, Bronsky EA, Dockhorn RJ, Kemp JP. Nathan RA, et al. Among authors: kemp jp. Ann Allergy. 1994 Mar;72(3):209-16. Ann Allergy. 1994. PMID: 8129213 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,436 results

Search Page

Filters